Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System

Project Title	Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System
Date Posted	Friday, December 6, 2019
Status	Complete
Deliverables	Sentinel Final Report: Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System
Related Links	Respiratory Syncytial Virus in a Pediatric Population Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness 2019 ICPE Poster: Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illnesses in Young Children
Description	FDA’s Sentinel System was used to characterize the epidemiology of respiratory syncytial virus-associated illness (RSV-AI) in U.S. children between 1 month and 5 years of age from January 2008 through June 2016. Greater than 80% of cases were managed as outpatients and >50% of hospitalized children, including those requiring intensive care, had no traditional risk factors besides young chronologic age.
Health Outcome	respiratory syncytial virus (RSV) respiratory syncytial virus-associated illness
Population / Cohort	Children 1 month to 5 years of age
Time Period	January 1, 2008 - June 30, 2016
Assessment Type	Exploratory Analyses
Study Type	Modular Program
Data Sources	Sentinel Distributed Database (SDD)
FDA Center	CDER

Search form